Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Green Planet Bio Engineering (GPLB) EPS (Weighted Average and Diluted) (2023 - 2026)

Green Planet Bio Engineering's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$0.0 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 60.0% to -$0.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.0, a 69.53% increase, with the full-year FY2025 number at -$0.0, down 0.84% from a year prior.
  • EPS (Weighted Average and Diluted) came in at -$0.0 for Q1 2026, up from -$0.0 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.0 in Q2 2025, with the low at -$0.0 in Q4 2025.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.0 across 4 years, with a median of -$0.0 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 62.21% in 2025 and later crashed 60.0% in 2026.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.0 in 2023, then increased by 5.6% to -$0.0 in 2024, then fell by 27.42% to -$0.0 in 2025, then skyrocketed by 32.85% to -$0.0 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GPLB at -$0.0 in Q1 2026, -$0.0 in Q4 2025, and -$0.0 in Q3 2025.